Pregled bibliografske jedinice broj: 702777
Metabolic syndrome is associated with higher postprandial glucagon-like peptide-1 in type 1 diabetes mellitus
Metabolic syndrome is associated with higher postprandial glucagon-like peptide-1 in type 1 diabetes mellitus // Diabetes 2014 ; 63 (Suppl. 1): A255-A255.
San Francisco (CA), Sjedinjene Američke Države, 2014. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 702777 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Metabolic syndrome is associated with higher postprandial glucagon-like peptide-1 in type 1 diabetes mellitus
Autori
Zibar, Karin ; Bulum, Tomislav ; Blaslov, Kristina ; Knežević-Ćuća, Jadranka ; Duvnjak, Lea
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Diabetes 2014 ; 63 (Suppl. 1): A255-A255.
/ - , 2014
Skup
73rd Scientific Sessions of American Diabetes Association
Mjesto i datum
San Francisco (CA), Sjedinjene Američke Države, 13.06.2014. - 17.06.2014
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
type 1 diabetes; metabolic syndrome; glucagon-like peptide-1
Sažetak
Metabolic syndrome (MS) is an important predictor of microvascular complications in type 1 diabetes mellitus (T1DM). Glucagon-like peptide 1 (GLP-1) analogues improve insulin resistance and other MS parameters. Higher plasma GLP-1 concentration was described in patients with MS, indicating GLP-1 resistance. Promising therapeutic effect of GLP-1 analogues in T1DM patients was proved, but there are no data regarding endogenous GLP-1 concentrations in T1DM patients with MS. We studied the relationship between plasma GLP-1 concentration and MS in a cross-sectional study including 30 T1DM patients, median age 37 years (20-59) and median disease duration of 22 (3-45) years. Fasting and postprandial (30 minutes) total GLP-1 concentrations was measured by ELISA (ALPCO, USA). MS was defined according to the NCEP: ATPIII criteria. Nonparametric statistics was used, with α level<0.05. The group of patients with MS (n=10) had higher postprandial GLP-1 concentrations compared to patients without MS (n=20), z=-2.26, p=0.023. Patients with MS were older and had longer disease duration. There was no difference in fasting total GLP-1 concentrations, glucoregulation (HbA1c) and calorie intake between the groups. We found higher postprandial total GLP-1 concentration in T1DM patients with MS. It could reflect a state of GLP-1 resistance, as already described in patients with MS, but without diabetes. Further studies are needed to clarify the pathophysiology of the finding.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Medicinski fakultet, Zagreb
Profili:
Lea Smirčić-Duvnjak
(autor)
Karin Zibar Tomšić
(autor)
Jadranka Knežević-Ćuća
(autor)
Tomislav Bulum
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE